EMTRICITABINE 200 mg + TENOFOVIR ALAFENAMIDE 25 mg (Tafero EM) x 30 Tablets

Benefits of TENOFOVIR ALAFENAMIDE 25 mg + EMTRICITABINE 200 mg

• Helps manage and control HIV infection
• Supports lowering the viral load in the body
• May help strengthen the immune system
• Commonly used as part of combination HIV therapy
• Supports long-term HIV treatment management
• Used under medical supervision

Side Effects

• Headache
• Nausea or upset stomach
• Tiredness or fatigue
• Diarrhea
• Insomnia (trouble sleeping)
• Skin rash (usually mild)
• Dizziness

Emtricitabine and Tenofovir Alafenamide Price and Reimbursement Information by Country

Emtricitabine and Tenofovir Alafenamide prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.

• View Emtricitabine with tenofovir alafenamide medicinal-form and pricing information on NICE BNF (UK) – https://bnf.nice.org.uk/drugs/emtricitabine-with-tenofovir-alafenamide/medicinal-forms/
• View Descovy (emtricitabine/tenofovir alafenamide) pricing information on Drugs.com (USA) – https://www.drugs.com/price-guide/descovy
• View Descovy PBS assessment information (Australia) – https://www.pbs.gov.au/industry/pbac/psd/2016/07/tenofovir-alafenamide-emtricitabine-psd-july-2016
• View Emtricitabine with tenofovir medicine information on MIMS (Singapore) – https://www.mims.com/singapore/drug/info/emtricitabine-plus-tenofovir?mtype=generic
• View Descovy reimbursement information from the Canadian drug review (Canada) – https://www.ncbi.nlm.nih.gov/books/NBK539225/